Clofarabine, Cytarabine and Mitoxantrone (CLAM) for Relapsed or Refractory AML
Clinical trial NCT02686593 · COMPLETED
Trial details
- NCT number
- NCT02686593
- Sponsor
- The University of Hong Kong
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2018-03-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.